To reduce the risk of hip and vertebral fractures in women with osteoporosis, physicians should treat them with the bisphosphonates risedronate, alendronate, or zoledronic acid, or alternatively with the biologic agent denosumab. This strong recommendation appears in revised guidelines from the American College of Physicians (ACP) for the prevention of fractures in men and women… Read more »
News
NOF Response to the Newly Published “Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians” (ACP) »
On Monday, May 8th, the American College of Physicians (ACP) released its updated guidelines for treatment of men and women with low bone density or osteoporosis. The National Osteoporosis Foundation (NOF) applauds the ACP for recognizing the need to update its previous guidelines from 2008 and emphasizing the importance of treatment for osteoporosis and the… Read more »
FDA Approves Radius Health’s TYMLOS™ (abaloparatide) »
Apr 28, 2017 FDA Approves Radius Health’s TYMLOS™ (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture TYMLOS is the first new anabolic (bone building) agent for postmenopausal women with osteoporosis in the United States in nearly 15 years US Commercial Launch in May Approval Based… Read more »
308 Health Advocates Urge Congress to Protect Patients & Oppose Government Intervention in Medicare Part D »
Washington, DC (February 21, 2017) – Today, the National Osteoporosis Foundation (NOF) and over 307 national and state health organizations urged legislators to protect patient access to medications by opposing proposals to allow the Secretary of Health and Human Services (HHS) to interfere in the Medicare Part D program. Specifically, the letter advocates for preserving… Read more »
Protect Patient Access to Medication »
Dear Member of Congress, We, the undersigned organizations, are writing to express opposition to proposals that would allow the Secretary of Health and Human Services (HHS) to interfere in private negotiations in the Medicare Part D program. We are concerned that such proposals could undermine Part D’s competitive structure and restrict access for millions of… Read more »
Medicare Part D Works and Congress Must Ensure Non-Interference Provision Remains In Place »
The National Osteoporosis Foundation (NOF) urges Members of Congress to oppose any amendment to repeal the non-interference provision of the Medicare Part D law. Senior citizens and people with disabilities have access to important, needed medications thanks to Medicare Part D. Part D provides this access and affordability for Medicare participants thanks to its competitive,… Read more »
NOF Appoints New Members to its Board of Trustees »
WASHINGTON, DC – The National Osteoporosis Foundation (NOF) today announced the approval of three new members to its Board of Trustees. The new trustees include: Blair Childs, Senior Vice President, Public Affairs for Premier, Inc.; Michael Cook, Co-Leader, Health Law Practice Group for Liles Parker Attorneys and Counselors at Law and Chris N. Sciamanna, MD,… Read more »
Calcium Supplements and the Heart: Clearing Up the Confusion »
A video interview was recorded with Dr. JoAnn Manson, professor of medicine at Harvard Medical School and Brigham and Women’s Hospital. She spoke about calcium supplements and the heart which is a subject that has been filled with mixed messages and prone to confusion over the past several years. Watch the recording here.
The NOF’s Methods and Processes for Developing Position Statements »
The National Osteoporosis Foundation frequently publishes position statements for the benefit of educating healthcare professionals and the general public on a particular issue and/or concern related to preventing osteoporosis and/or promoting strong bones throughout the lifespan. This manuscript represents the official methods and processes adopted by the NOF Board of Trustees for the purpose developing… Read more »
NOF Response to Report in the Journal of the American Heart Association that Calcium Supplements May Damage the Heart »
We have read and reviewed the report on observational research, published Oct. 10 in the Journal of the American Heart Association, which concludes that taking calcium in the form of supplements may raise the risk of atherosclerosis as assessed by calcium deposits in the coronary arteries, although a diet high in calcium-rich foods appears to… Read more »